Understanding inborn errors of immunity: A lens into the pathophysiology of monogenic inflammatory bowel disease
Open Access
- 29 September 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 1026511
Abstract
Inflammatory bowel diseases (IBD) are chronic inflammatory conditions of the gastrointestinal tract, including Crohn’s disease, ulcerative colitis and inflammatory bowel disease-undefined (IBD-U). IBD are understood to be multifactorial, involving genetic, immune, microbial and environmental factors. Advances in next generation sequencing facilitated the growing identification of over 80 monogenic causes of IBD, many of which overlap with Inborn errors of immunity (IEI); Approximately a third of currently identified IEI result in gastrointestinal manifestations, many of which are inflammatory in nature, such as IBD. Indeed, the gastrointestinal tract represents an opportune system to study IEI as it consists of the largest mass of lymphoid tissue in the body and employs a thin layer of intestinal epithelial cells as the critical barrier between the intestinal lumen and the host. In this mini-review, a selection of pertinent IEI resulting in monogenic IBD is described involving disorders in the intestinal epithelial barrier, phagocytosis, T and B cell defects, as well as those impairing central and peripheral tolerance. The contribution of disrupted gut-microbiota-host interactions in disturbing intestinal homeostasis among patients with intestinal disease is also discussed. The molecular mechanisms driving pathogenesis are reviewed along with the personalized therapeutic interventions and investigational avenues this growing knowledge has enabled.Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases
This publication has 145 references indexed in Scilit:
- Aire and T cell developmentCurrent Opinion in Immunology, 2011
- Hereditary multiple intestinal atresia (HMIA) with severe combined immunodeficiency (SCID): a case report of two siblings and review of the literature on MIA, HMIA and HMIA with immunodeficiency over the last 50 yearsBMJ Case Reports, 2011
- Residual NADPH Oxidase and Survival in Chronic Granulomatous DiseaseNew England Journal of Medicine, 2010
- Complications of Tumor Necrosis Factor–α Blockade in Chronic Granulomatous Disease–Related ColitisClinical Infectious Diseases, 2010
- Inflammatory Bowel Disease and Mutations Affecting the Interleukin-10 ReceptorNew England Journal of Medicine, 2009
- Familial Hemophagocytic Lymphohistiocytosis Type 5 (FHL-5) Is Caused by Mutations in Munc18-2 and Impaired Binding to Syntaxin 11The American Journal of Human Genetics, 2009
- Twenty-Year Follow-Up of Esophageal Involvement in Chronic Granulomatous DiseaseAmerican Journal of Gastroenterology, 2009
- The gut microbiota shapes intestinal immune responses during health and diseaseNature Reviews Immunology, 2009
- Mechanisms controlling expression of the RAG locus during lymphocyte developmentCurrent Opinion in Immunology, 2009
- A pathogenic dyskerin mutation impairs proliferation and activates a DNA damage response independent of telomere length in miceProceedings of the National Academy of Sciences, 2008